SE8901715L - A PLASMID DNA CONSTRUCTION CONTAINING DNA SEQUENCES - Google Patents

A PLASMID DNA CONSTRUCTION CONTAINING DNA SEQUENCES

Info

Publication number
SE8901715L
SE8901715L SE8901715A SE8901715A SE8901715L SE 8901715 L SE8901715 L SE 8901715L SE 8901715 A SE8901715 A SE 8901715A SE 8901715 A SE8901715 A SE 8901715A SE 8901715 L SE8901715 L SE 8901715L
Authority
SE
Sweden
Prior art keywords
dna sequences
plasmid
construction containing
dna
beta
Prior art date
Application number
SE8901715A
Other languages
Unknown language ( )
Swedish (sv)
Inventor
L Olsson
Original Assignee
Lope Medicine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lope Medicine Ab filed Critical Lope Medicine Ab
Priority to SE8901715A priority Critical patent/SE8901715L/en
Priority to AU56741/90A priority patent/AU5674190A/en
Priority to JP2508094A priority patent/JPH04506150A/en
Priority to PCT/SE1990/000301 priority patent/WO1990013650A1/en
Priority to EP19900908705 priority patent/EP0471787A1/en
Publication of SE8901715L publication Critical patent/SE8901715L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A plasmid DNA construct comprising essentially DNA sequences endogenous to mammalian cells excluding DNA sequences of viral origin including the gene encoding a mammalian beta -nerve growth factor ( beta -NGF) or an active polypeptide fragment thereof, and DNA sequences necessary for replicating the plasmid in a bacterial cell; and a method for the treatment of neurodegenerative diseases.
SE8901715A 1989-05-12 1989-05-12 A PLASMID DNA CONSTRUCTION CONTAINING DNA SEQUENCES SE8901715L (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8901715A SE8901715L (en) 1989-05-12 1989-05-12 A PLASMID DNA CONSTRUCTION CONTAINING DNA SEQUENCES
AU56741/90A AU5674190A (en) 1989-05-12 1990-05-08 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor
JP2508094A JPH04506150A (en) 1989-05-12 1990-05-08 Plasmid DNA constructs and their uses
PCT/SE1990/000301 WO1990013650A1 (en) 1989-05-12 1990-05-08 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor
EP19900908705 EP0471787A1 (en) 1989-05-12 1990-05-08 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901715A SE8901715L (en) 1989-05-12 1989-05-12 A PLASMID DNA CONSTRUCTION CONTAINING DNA SEQUENCES

Publications (1)

Publication Number Publication Date
SE8901715L true SE8901715L (en) 1990-11-13

Family

ID=20375943

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901715A SE8901715L (en) 1989-05-12 1989-05-12 A PLASMID DNA CONSTRUCTION CONTAINING DNA SEQUENCES

Country Status (5)

Country Link
EP (1) EP0471787A1 (en)
JP (1) JPH04506150A (en)
AU (1) AU5674190A (en)
SE (1) SE8901715L (en)
WO (1) WO1990013650A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1500399A1 (en) * 2003-07-24 2005-01-26 Institut Pasteur Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (en) * 1983-03-03 1991-11-11 Genentech Inc POLYPEPTIDE OF PROPERTIES AS HUMAN BETA-NERVE GROWTH FACTOR AND METHOD FOR PREPARATION THEREOF, DNA ISOLAT comprising a sequence encoding the polypeptide is replicable expression vector for DNA SEQUENCE recombinant host cell transformed with the vector, pharmaceutical composition comprising the polypeptide and be stated in. THAT INCLUDES THE APPLICATION OF THE POLYPEPTID IN FORCE. OF A PHARMACEUTICAL PREPARATION

Also Published As

Publication number Publication date
WO1990013650A1 (en) 1990-11-15
AU5674190A (en) 1990-11-29
JPH04506150A (en) 1992-10-29
EP0471787A1 (en) 1992-02-26

Similar Documents

Publication Publication Date Title
AU560340B2 (en) Rennin from recombinant dna
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
DK639689D0 (en) INTRODUCING DNA IN CELLS
DK506488A (en) PROCEDURE FOR CULTIVATING RECOMBINANT CELLS, HOST CELL USE FOR PROCEDURE AND CULTURE COVERING THE HOST CELL
DE69635864D1 (en) RECOMBINANT RNA REPLICASE OF HEPATITIS C VIRUS
ZA942778B (en) Recombinant viruses, and their preparation and use in gene therapy.
ES8800987A1 (en) Production of factor viii and related products.
ES2013324A6 (en) Eucaryotic expression system.
AU682140B2 (en) Multidrug resistance gene
DK1508620T3 (en) Circular DNA molecule with conditional origin of replication, methods for its preparation and use in gene therapy
DE69920747D1 (en) METHOD FOR THE PRODUCTION OF RECOMBINANT CELLS
FI885679A0 (en) SAMUTTRYCKNING I EUKARIOTISKA CELLER.
ATE177472T1 (en) EXPRESSION OF MACROPHAGE-INDUCABLE PROTEINS (MIPS) IN YEAST CELLS
ES8801376A1 (en) Hybrid protein
EP0111814A3 (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
KR880700855A (en) Improved method of expressing eukaryotic proteins
GR3031229T3 (en) Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease
SE8901715L (en) A PLASMID DNA CONSTRUCTION CONTAINING DNA SEQUENCES
EP0282330A3 (en) Method for stimulating gene expression
AUPM772494A0 (en) Improvements in production of proteins in host cells
FR2600079B1 (en) VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN F OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A, CELL CULTURE INFECTED WITH THIS VECTOR, PROCESS FOR PREPARING THE PROTEIN, OBTAINED PROTEIN, VACCINE AND ANTIBODIES OBTAINED
DE69923595D1 (en) PREPARATION OF PROTEINS
NO179453C (en) Method of Preparation of Therapeutically Active Amphiregulin, Host Cell Producing Protein, Recombinant Vector Contained in the Host Cell, and Nucleotide Sequence Encoding Proteins with Amphiregulin Activity
JPS6485094A (en) Novel physiologically active polypeptide

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8901715-6

Effective date: 19940818